$LALPATHLAB share price in focus: Emkay bullish on BSE 500 company; maintains buy call - 5 reasons why

Dr Lal PathLabs share price in focus: Dr Lal PathLabs on Thursday (April 30) declared its Q4 quarterly results for the financial year 2025-26. Along with the quarterly earnings, the BSE 500 company also declared a final dividend of Rs 4 per equity share for FY26. Dr Lal PathLabs share price in focus: Emkay bullish on BSE 500 company; maintains buy call - 5 reasons why